Mark Eisner Vir Biotechnology, Inc. (VIR) insider trading activity

VIR Quotes by TradingView

Mark Eisner is EVP and Chief Medical Officer of Vir Biotechnology, Inc.. Currently has a direct ownership of 104,618 shares of VIR, which is worth approximately $531,459. The most recent transaction as insider was on Jul 17, 2025, when has been sold 3,586 shares (Common Stock) at a price of $5.47 per share, resulting in proceeds of $19,615. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 105K
9.03% 3M change
39.49% 12M change
Total Value Held $531,459

Mark Eisner Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jul 17 2025
SELL
Open market or private sale
$19,615 $5.47 p/Share
3,586 Reduced 3.31%
104,618 Common Stock
Jul 15 2025
SELL
Open market or private sale
$37,174 $5.47 p/Share
6,796 Reduced 5.91%
108,204 Common Stock
Feb 22 2025
BUY
Grant, award, or other acquisition
-
40,000 Added 25.81%
115,000 Common Stock
Jul 15 2024
BUY
Grant, award, or other acquisition
-
75,000 Added 50.0%
75,000 Common Stock

Also insider at

FGEN
FIBROGEN INC Healthcare
EVP, Chief Medical Officer
ME

Mark Eisner

EVP and Chief Medical Officer
San Francisco, CA

Track Institutional and Insider Activities on VIR

Follow Vir Biotechnology, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells VIR shares.

Notify only if

Insider Trading

Get notified when an Vir Biotechnology, Inc. insider buys or sells VIR shares.

Notify only if

News

Receive news related to Vir Biotechnology, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on VIR